. Intraoperative Pyloric Botulinum Toxin Injection for Post Total Pancreatectomy With Islet Autotransplantation Gastroparesis Improvement in Children. Journal of Pediatric Surgery. 2025; 60:162341.
. Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure. EJC Paediatric Oncology. 2025; 5:100235.
. Real-world Multi-institutional Data From the Midwest Pediatric Surgery Consortium (MWPSC) to Assess the Effect of Delayed Kasai Procedure on Biliary Drainage in Patients With Biliary Atresia. Journal of Pediatric Surgery. 2025; 60:162250.
. Surgical management of liver tumors. Pediatric Blood and Cancer. 2025; 72 Suppl 2:e31155.
. Management, Trends, and Recommendations for Intra-abdominal Lymphatic Malformations: A Single-Center Retrospective Review. Journal of Pediatric Surgery. 2025; 60:162223.
. Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation. Pediatric Transplantation. 2025; 29:e70035.
. Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers. Pediatric Hematology-Oncology (Informa). 2025; 42:1-13.
. Revision Kasai portoenterostomy: A review of indications and outcomes. Seminars in Pediatric Surgery. 2025; 33:151476.
. Kasai Vs Primary Liver Transplantation: Optimizing the Surgical Approach for Patients Diagnosed with Biliary Atresia. Difficult Decisions in Pediatric Surgery. : Springer Nature; Springer Nature; 2025.
. Development and Validation of a Pediatric Donor Liver Risk Score (PeDLRS) to Predict 1-Year Graft Loss or Mortality in Pediatric Liver Transplant Recipients. American Journal of Transplantation. 2025; 25:s18-s19.
. Racial and Ethnic Survival Disparities in Pediatric Oncology Over Time: An Analysis of the SEER Registry. Journal of Pediatric Surgery. 2025; 60:161953.
. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers. 2025; 17:83.
. Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome. Pediatric Blood and Cancer. 2025; 72:e31389.
. Endoscopic cystostomy and biliary sphincterotomy for choledochoceles: A pediatric case series. 2024; 5:475-479.
. Single-Center Case Series of Congenital Anomalies of the Kidney and Urinary Tract and Hepatoblastoma. Journal of the American Society of Nephrology : JASN. 2024; 35:10.1681/asn.20241j3dwf9j.
. Specific binding sites on Rhesus rotavirus capsid protein dictate the method of endocytosis inducing the murine model of biliary atresia. American Journal of Physiology: Gastrointestinal and Liver Physiology. 2024; 327:G267-G283.
. Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers. Cancers. 2024; 16:2300.
. Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study. Pediatric Blood and Cancer. 2024; 71:e30975.
. Children's Oncology Group's 2023 blueprint for research: Surgery. Pediatric Blood and Cancer. 2024; 71:e30766.
. EZH2 is a key component of hepatoblastoma tumor cell growth. Pediatric Blood and Cancer. 2024; 71:e30774.
. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma. Hepatology Communications. 2024; 8:e0369.
. Intrahepatic Cholangiolitis in Cystic Fibrosis (ICCF): An Under-Appreciated Cause of Persistent Cholestasis in Infancy. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2024; 27:13-22.
. Critical elements of pediatric liver cancer surgery. Seminars in Pediatric Surgery. 2023; 32:151340.
. Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia. Journal of Interferon and Cytokine Research. 2023; 43:427-434.
. Children's Oncology Group's 2023 blueprint for research: Liver tumors. Pediatric Blood and Cancer. 2023; 70 Suppl 6:e30576.
. Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience. Cancers. 2023; 15:3921.
. Customized Postoperative Therapy Improves Bile Drainage in Biliary Atresia: A Single Center Preliminary Report. Journal of Pediatric Surgery. 2023; 58:1483-1488.
. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatric Blood and Cancer. 2023; 70:e30365.
. Anti-thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients. Pediatric Transplantation. 2023; 27:e14509.
. Advancing the Field of Pediatric Liver Transplantation: Urgent Action Items Identified During the 2022 Society of Pediatric Liver Transplantation Meeting. Transplantation. 2023; 107:1223-1225.
. Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma. Children. 2023; 10:890.
. Editorial: Infants with cholestasis. Frontiers in Pediatrics. 2023; 11:1175231.
. Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023; 77:530-545.
. 10 Year Analysis of Pediatric Surgery Fellowship Match and Operative Experience: Concerning Trends?. Annals of Surgery. 2023; 277:e475-e482.
. Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma. Cancers. 2022; 14:6062.
. Children undergoing early liver re-transplantation for primary non-function have improved survival. Pediatric Transplantation. 2022; 26:e14347.
. β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma. Hepatology Communications. 2022; 6:2950-2963.
. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. Journal of Hepatology. 2022; 77:1026-1037.
. Rhesus rotavirus receptor-binding site affects high mobility group box 1 release, altering the pathogenesis of experimental biliary atresia. Hepatology Communications. 2022; 6:2702-2714.
. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. Journal of Pediatric Surgery. 2022; 57:251-256.
. Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. Hepatology. 2022; 76:712-726.
. The Outcome of Patients With Cystic Biliary Atresia With Intact Proximal Hepatic Ducts Following Hepatic-Cyst-Jejunostomy. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75:131-137.
. Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases-Examination of cholestatic liver disease in Alagille syndrome. Hepatology Communications. 2022; 6:1910-1921.
. Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study. Cancer. 2022; 128:2786-2795.
. Pediatric Living Donor Liver Transplantation Outcomes-Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?. Liver Transplantation. 2022; 28:928-930.
. Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT). American Journal of Transplantation. 2022; 22:1396-1408.
. Underestimating and Underdiagnosing Biliary Atresia: We Can Do Better. Liver Transplantation. 2022; 28:756-757.
. Planned Preterm Delivery and Treatment of Severe Infantile FEVR With Osteoporosis-Pseudoglioma Syndrome. OSLIRetina. 2022; 53:228-232.
. Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer. 2022; 128:1057-1065.
. Relation of Liver Volume to Adverse Cardiovascular Events in Adolescents and Adults With Fontan Circulation. American Journal of Cardiology. 2022; 165:88-94.
. Developing an adolescent and adult Fontan Management Programme. Cardiology in the Young. 2022; 32:230-235.
. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. Journal of Clinical Oncology. 2022; 40:459-467.
. Urinary 11-dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid-organ transplant patients. Pediatric Blood and Cancer. 2022; 69:e29413.
. Portal Hypertension. Fundamentals of Pediatric Surgery. : Springer Nature; Springer Nature; 2022.
. Neurodevelopmental Outcomes in Children With Inherited Liver Disease and Native Liver. Journal of Pediatric Gastroenterology and Nutrition. 2022; 74:96-103.
. Congenital Intrahepatic Cholestasis. Fundamentals of Pediatric Surgery. : Springer Nature; Springer Nature; 2022.
. T-Bet Deficiency Attenuates Bile Duct Injury in Experimental Biliary Atresia. Cells. 2021; 10:3461.
. Bridge to Heart-Liver Transplantation With a Ventricular Assist Device in the Fontan Circulation. Circulation: Heart Failure. 2021; 14:e008018.
. Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma. Communications Biology. 2021; 4:1049.
. Single incision laparoscopic lysis of adhesions. Journal of Pediatric Surgery Case Reports. 2021; 74:102060.
. Isolation and Culturing Primary Chaolangiocytes from Mouse Liver. Bio-protocol. 2021; 11:e4192.
. Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models. Hepatology. 2021; 74:2201-2215.
. Operational tolerance after pediatric composite liver-pancreas-intestine transplantation following severe graft-versus-host disease. Pediatric Transplantation. 2021; 25:e14069.
. High Mobility Group Box 1 Release by Cholangiocytes Governs Biliary Atresia Pathogenesis and Correlates With Increases in Afflicted Infants. Hepatology. 2021; 74:864-878.
. Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma. Cancer Medicine. 2021; 10:4322-4343.
. Variability in age at Kasai portoenterostomy for biliary atresia across US children's hospitals. Journal of Pediatric Surgery. 2021; 56:1196-1202.
. Liver Tumors in Pediatric Patients. Surgical Oncology Clinics of North America. 2021; 30:253-274.
. Biliary Atresia and Other Disorders of the Extrahepatic Bile Ducts. Liver Disease in Children. : Cambridge University Press (CUP); Cambridge University Press (CUP); 2021.
. HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2021; 12:1669-1682.